首頁 > 北榮簡介 > 正副院長介紹 > 高副院長 壽延

:::
正副院長介紹
:::
高副院長 壽延
A- A A+

副院長

高副院長壽延

 高副院長 壽延

姓名：

高壽延

服務機構：

臺北榮民總醫院

現職：

臺北榮民總醫院 副院長

地址：

112臺北市北投區石牌路二段201號

電話：

886-2-2875-7572-7155

學歷：

美國哈佛大學牙醫學院口腔癌分子生物研究所博士
長庚大學醫務管理研究所碩士

經歷：

陽明大學專任助教、臺北榮民總兼任住院醫師(1986-1991)
國科會公費留學(1993-1996)
陽明大學牙醫校友會會長，創辦萌芽會刊(1997-1999)
中華民國醫院牙科協會秘書長(2000-2002)
中華牙醫學會秘書長/理事(2001-2003-2005)
臺北榮民總醫院口腔醫學部口腔顎面外科主任(2003-2008)
陽明大學牙醫學院副院長(2010-2014)
亞洲口腔顎面外科學會候選理事長(2010-2013)
中華民國口腔顎面外科學會理事長(2011-2013)
第13屆2018亞洲口腔顎面外科學大會籌委會主委(2015)
亞洲口腔顎面外科學會籌備理事長(2016-2018)

現職：

臺北榮民總醫院副院長
陽明大學牙醫學院合聘教授

榮譽獎項：

中華醫學會年度住院醫師組最佳論文獎(1990)
臺北榮民總牙科部年度最佳論文獎(1991)
臺北榮民總年度臨床工作績優獎(1992)
臺北榮民總醫院年度服務工作績優獎個人組第一名(2000)
陽明大學醫學系學生遴選優良教師(2004)
93年度行政院退除役官兵輔導委員會優良醫師(2004)
臺北榮民總醫療技術創新獎(2006)
臺北榮民總醫院年度廉政楷模(2012)
口腔醫學部獲廉政倫理獎(2013)
臺北榮民總醫院年度優良醫師(2013)
陽明大學行政類傑出校友(2013)
領導口腔癌團隊獲衛福部卓越計劃(2014)
104年行政院模範公務員(2015)
領導口腔癌團隊通過生策會 SNQ標章認證(2016)

專長：

口腔顎面外科學、口腔腫瘤學、牙醫學、醫務管理

學術研究論文：

LinIC, Anne MG, Chang,HJ, KaoSY, Chen DW. A 5-Year Follow-up of 80 Implants in 44 Patients Placed Immediately After the Lateral Trap-Door Window Procedure to Accomplish Maxillary Sinus Elevation Without Bone Grafting. The International Journal of Oral & Maxillofacial Implants :26,1079-86, 2011.(SCI)  

Kao SY , Lo WL.Screening for oral cancers-Which method is most effective?J CHIN MED ASSOC:74(12) :529-530.2011. (SCI)

Kuo YL,Tu TY,  Chang CF,  LiWY,  Chang SY,Shiao AS,  Chu PY,Chan KT,  Tai SK,  Wang YF,  Kao SC,  Kao SY,  Lo WL,  Wu CH,  Shu WH,  Ma S,  Wang TH.Extra-major salivary gland pleomorphic adenoma of the head and neck: a 10-year experience and review of the literature.EUR ARCH OTO-RHINO-L:268(7) :1035-1040.2011. (SCI)

Lo WL,  Lai JY,  Feinberg SE,  Izumi K,  Kao SY,  Chang CS,  LinA,  Chiang HK.Raman spectroscopy monitoring of the cellular activities of a tissue-engineered ex vivo produced oral mucosal equivalent.J RAMAN SPECTROSC:42(2) :174-178.2011. (SCI)

Lo WL, Yu CC,Chiou GY,  Chen YW,  Huang PI,Chien CS,  Tseng LM,  Chu PY,  Lu KH,  Chang KW,  Kao SY,Chiou SH.MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.J PATHOL.223(4) :482-495.2011. (SCI)

Tseng YH, Chang KW, Yang CC, Liu CJ, Kao SY, Liu TY, Lin SC*. Association between areca-induced vimentin expression and oral cancer progression.HEAD & NECK, 10.1002:245-253 2012.(SCI)

Tu HF, Liu CJ, Chang CL, WangPW, Kao SY, Yang CC, Yu EH, Lin SC, Chang KW.The Association between Genetic Polymorphism and the Processing Efficiency of miR-149 Affects the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.PLoS One Article Number :14 ;7(12).2012. (SCI)

Yang WH, Lan HY, Huang CH, Tai SK,Tzeng CH, Kao SY, Wu KJ,  Hung MC, Yang MH.RAC1 activation mediates Twist1-induced cancer cell migration.Nature cell biology: 14(4) :366-74.2012. (SCI)

Hung PS, Chang KW, Kao SY, Chu TH, Liu CJ, Lin SC.Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression.Oral oncology:48(5) :404-408.2012. (SCI)

Chen YW, Chen CY, Chiang SC,Lui MT, Kao SY, Yang MH.Predictors and impact of microsurgical complications in patients with locally advanced oral squamous cell carcinoma.Cancer science: 103(9) :1672-1678.2012. (SCI)

Lo WL,* Chu PY, Lee TH, Su TL, Chien Y, Chen YW, Huang PI, Tseng LM , Tu PH , Kao SY and Lo JF. A Combined DNA-Affinic Molecule and N-Mustard Alkylating Agent Has an Anti-Cancer Effect and Induces Autophagy in Oral Cancer Cells. Int. J. Mol. Sci. 13(3), 3277-3290, 2012(SCI)

Chen YW, Kao SY, Yang MH. Analysis of p16INK4A. Expression of Oral Squamous Cell Carcinomas in Taiwan:Prognostic Correlation Without Relevance to Betel Quid Consumption. Journal of Surgical Oncology: 106, 149–154, 2012. (SCI)

Chen YW, Kao SY, Wang HJ, Yang MH.Histone modification patterns correlate with patient outcome in oral squamous cell carcinoma.Cancer. Dec 15;119(24):4259-67, 2013. (SCI)

Chen YS, Huang WL, Chang SH, Chang KW, Kao SY, Lo JF, Su PF.Enhanced filopodium formation and stem-like phenotypes in a novel metastatic head and neck cancer cell model.Oncol Rep. Dec;30(6):2829-37, 2013. (SCI)

Chang KW, Kao SY, Wu YH, Tsai MM, Tu HF, Liu CJ, Lui MT, Lin SC. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA. Oral oncology:49(1) ,27-33.2013 (SCI)

Hung PS, Liu CJ, Chou CS, Kao SY, Yang CC,Chang KW, Chiu TH, Lin SC. miR-146a Enhances the Oncogenicity of Oral Carcinomaby Concomitant Targeting of the IRAK1, TRAF6 andNUMB Genes. PLOS ONE: 8(11), 1-17. 2013. (SCI)

Yu EH, Lui MT, Tu HF, Wu CH, Lo WL, Yang CC, Chang KW, Kao SY. Oral carcinoma with perineural invasion has higher nervegrowth factor expression and worse prognosis. Oral Diseases: 20, 268–274. 2014. (SCI)

Chen YW, Chen IL, Lin IC, Kao SY. Prognostic value of hypercalcaemia and leucocytosis in resected oral squamous cell carcinoma. Brit J Oral Max Surg: MAY ;52(5) :425-431, 2014. (SCI)

Hung PS,Tu HF, Kao SY, Yang CC, Liu CJ, Huang TY, Chang KW, Lin SC. miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes. Carcinogenesis: 35(5) .2014, (SCI)

Liu CJ, Shen WG, Peng SY, Cheng HW, Kao SY, Lin SC, Chang KW. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene. Int J Cancer: FEB ;134(4) :811-821.2014. (SCI)

Lin SP, Chiu FY, Wang Y, Yen ML, Kao SY, Hung SC.RB Maintains Quiescence and Prevents Premature Senescence through Upregulation of DNMT1 in Mesenchymal Stromal Cells.Stem Cell Reports:December  2014. (SCI)

Kao SY, Tsai MM, Wu CH, Chen JJ, Tseng SH, Lin SC, Chan KW.Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas.Head Neck; 2014. (SCI)

Lu WC, Kao SY, Yang CC, Tu HF, Wu CH, Chang KW, Lin SC. EGF up-regulates miR-31 through the C/EBP β signal cascade in oral carcinoma. PLoS One. 2014. (SCI)

Kao SY, Lui MT, Cheng DH, Chen TW. Lateral trap-door window approach with maxillary sinus membrane lifting for dental implant placement in atrophied edentulous alveolar ridge. J Chin Med Assoc 2015; 78: 85-88. 

Kao SY, LIM Elva. An Overview of Detection and Screening of Oral Cancer in Taiwan. The Chinese Journal of Dental Research. 2015; 7-14.

Kao SY, Mao l, Jian XC, GunaseelanRajan, Yu KY. Expert consensus on the detection and screening or oral cancer and precancer. The Chinese Journal of Dental Research. 2015; 18:79-84.

Kao YY, Tu HF, Kao SY, Chang KW, Lin SC.The increase of oncogenic miRNA expression in tongue carcinogenesis of a mouse model.Oral Oncol. 2015 Dec;51(12):1103-12.

Hung KF, Liu CJ, Chiu PC, Lin JS, ChangKW, Shih WY, Kao SY, Tu HF. MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder. Oral Oncology. 201653:42–47

Wang L, Chen YW, Ho CY, Hsueh Liu YW, Chou FI, Liu YH, Liu HM, Peir JJ, Jiang SH, Chang CW, Liu CS, Lin KH,Wang SJ, Chu PY, Lo WL, Kao SY, Yen SH. Fractionated Boron Neutron Capture Therapy in Locally Recurrent Head and Neck Cancer: A Prospective Phase I/II Trial.Int J Radiation OncolBiol Phys. 2016 .95(1):396-403.

Huang HC, Kao SY, Chen SY, Yang CC. Osteosarcoma of mandible– A case report.  Taiwan J oral Maxillofac Surg. 2016.27(1): 38-45.

　

最後更新：